Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers
Clinical trial NCT00192296 · COMPLETED
Trial details
- NCT number
- NCT00192296
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2005-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.